Archive News
-
Prevas presents its financial targets for the company
Prevas has developed steadily and strongly in recent years, and the final quarter of 2021 was marked by several records. Now is the time to clarify ambitions and financial goals going forward. Prevas’ management team and board of directors have thus reviewed and set the company's financial targets.
Read more
-
Prevas Year-End Report 2021
Prevas reaches all-time highs. Proposed dividend 3.50 SEK/share (2.0).
Read more
-
Automated flows minimize manual tasks at McNeil
When the pharmaceutical company McNeil in Helsingborg was to upgrade its PAS-X, the overall MES system that controls and monitors large parts of their production, Prevas was engaged to develop Middleware that minimizes the risk of incorrect manual entries.
Read more
References
-
Nipro Medical Europe
Prevas UX/UI-expertise helps Nipro choose the right solutions within new design concept
-
Moelven
Automated planning frees resources at Moelven
-
Gradientech
Ultra-fast diagnostics system can save lives and counteract antibiotic resistance
-
4Life Solutions
Clean drinking water in four hours
Follow us on social media
